Back to search

Lion's Mane, Yamabushitake · 2015 · Research Support, Non U.S. Gov'T

Medium relevance

A new cerebroside from the fruiting bodies of Hericium erinaceus and its applicability to cancer treatment.

Hericium erinaceus

OncologyCognition & nerves
SpeciesLion's Mane, Yamabushitake
JournalBioorganic & medicinal chemistry letters
Year2015

Key points

  • A new cerebroside, cerebroside E (1) was isolated from the fruiting bodies of Hericium erinaceus (Hericiaceae)
  • The structure of 1 was elucidated by a combination of extensive spectroscopic analyses, including extensive 2D NMR, HR-MS, and chemical reactions
  • Compound 1 was evaluated for its applicability to medicinal use in several human diseases using cell-based assays
  • As a result, compound 1 attenuated cisplatin-induced nephrotoxicity in LLC-PK1 cells and exhibited a significant inhibitory effect on angiogenesis in HUVECs
  • These results collectively reflect the beneficial effects of compound 1 in cancer treatment

Metadata-grounded summary

Citation abstract

A new cerebroside, cerebroside E (1) was isolated from the fruiting bodies of Hericium erinaceus (Hericiaceae). The structure of 1 was elucidated by a combination of extensive spectroscopic analyses, including extensive 2D NMR, HR-MS, and chemical reactions. Compound 1 was evaluated for its applicability to medicinal use in several human diseases using cell-based assays. As a result, compound 1 attenuated cisplatin-induced nephrotoxicity in LLC-PK1 cells and exhibited a significant inhibitory effect on angiogenesis in HUVECs. These results collectively reflect the beneficial effects of compound 1 in cancer treatment.

Citation

Lee SR, Jung K, Noh HJ, Park YJ, Lee HL, Lee KR, et al. (2015). A new cerebroside from the fruiting bodies of Hericium erinaceus and its applicability to cancer treatment. Bioorganic & medicinal chemistry letters https://doi.org/10.1016/j.bmcl.2015.10.092 PMID: 26547693

Open citation